Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: The ERECT Trial

Eur Urol Focus. 2019 Jul;5(4):698-699. doi: 10.1016/j.euf.2018.01.002. Epub 2018 Jan 17.


Erythropoietin receptors have been localized to human penile tissue and periprostatic neurovascular bundles. ERECT is a placebo-controlled, phase 2, randomized trial assessing the effect of erythropoietin on recovery of erectile function for men undergoing radical prostatectomy for prostate cancer.

Publication types

  • Clinical Trial Protocol

MeSH terms

  • Clinical Trials, Phase II as Topic
  • Erectile Dysfunction / drug therapy*
  • Erythropoietin / therapeutic use*
  • Humans
  • Male
  • Postoperative Complications / etiology*
  • Prostatectomy*
  • Prostatic Neoplasms / surgery*
  • Randomized Controlled Trials as Topic
  • Recovery of Function


  • EPO protein, human
  • Erythropoietin